新的HLA-C*07:1088等位基因以两种不同的基于测序的类型技术为特征
Michaël Pérès1, Adèle Dhuyser1,2, Thomas Morel1
1HLA and Histocompatibility Laboratory, CHRU de Nancy, Vandœuvre-lès-Nancy, France.
HLA
|May 16, 2025
概括
一个新的人类白细胞抗原 (HLA) 基因,HLA-C*07:1088,已被确定. 这种新型HLA基因基因因与已知的HLA-C*07:01:01:01有单个核酸替代的差异.
科学领域:
- 免疫遗传学 免疫遗传学
- 分子生物学分子生物学
- 人类白细胞抗原 (HLA) 研究
背景情况:
- 人类白细胞抗原 (HLA) 系统在免疫反应中起着至关重要的作用.
- 在HLA等位基因的遗传变异有助于各种免疫功能和疾病易感性.
- 对新型HLA等位基因的准确表征对于免疫学研究和临床应用至关重要.
研究的目的:
- 报告发现和初步表征一种新的HLA等位基因.
- 详细说明新型等位基因与已知的参考等位基因之间的特定遗传差异.
主要方法:
- 新型等位基因的序列分析.
- 将新型等位基因的序列与现有的HLA等位基因数据库进行比较.
- 核酸替代物及其位置的识别.
主要成果:
- 一个新的HLA等位基因被确定,被指定为HLA-C*07:1088.
- 这种新等位基因通过单个核酸替代与HLA-C*07:01:01:01不同.
- 这种替代是非同义的,位于HLA-C基因的第3个外显子中.
结论:
- 鉴定HLA-C*07:1088扩大了已知的HLA-C等位基因库.
- 这种单个核酸替代代表了这种新型等位基因的特定遗传标记.
- 需要进一步的研究来了解HLA-C*07:1088.8的潜在功能和临床影响.
相关概念视频
01:05Single Nucleotide Polymorphisms-SNPs
13.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
13.7K
01:11Genome-wide Association Studies-GWAS
12.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.2K